BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 35950873)

  • 1. Antibiotic Maintenance and Redevelopment of Nontuberculous Mycobacteria Pulmonary Disease after Treatment of Mycobacterium avium Complex Pulmonary Disease.
    Zo S; Kim H; Kwon OJ; Jhun BW
    Microbiol Spectr; 2022 Aug; 10(4):e0108822. PubMed ID: 35950873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological Cure at Treatment Completion Is Associated With Longer Survival in Patients With Mycobacterium avium Complex Pulmonary Disease.
    Kim JY; Park J; Choi Y; Kim TS; Kwak N; Yim JJ
    Chest; 2023 Nov; 164(5):1108-1114. PubMed ID: 37423256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality.
    Im Y; Hwang NY; Kim K; Kim H; Kwon OJ; Jhun BW
    Chest; 2022 May; 161(5):1192-1200. PubMed ID: 34793759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Lung Disease in Patients With Mycobacterium avium Complex Lung Disease.
    Furuuchi K; Fujiwara K; Uesgi F; Shimoda M; Seto S; Tanaka Y; Yoshiyama T; Yoshimori K; Kurashima A; Ohta K; Morimoto K
    Clin Infect Dis; 2021 Jul; 73(1):e152-e157. PubMed ID: 32507892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.
    Asakura T; Nakagawa T; Suzuki S; Namkoong H; Morimoto K; Ishii M; Kurashima A; Betsuyaku T; Ogawa K; Hasegawa N;
    J Infect Chemother; 2019 Mar; 25(3):218-221. PubMed ID: 30172726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece - relation to microbiological data.
    Manika K; Tsikrika S; Tsaroucha E; Karabela S; Karachaliou I; Bosmi I; Kioumis I; Papavasileiou A
    Future Microbiol; 2015; 10(8):1301-6. PubMed ID: 26226382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in Mycobacterium xenopi versus Mycobacterium avium complex pulmonary disease: A retrospective matched cohort study.
    Zaheen A; Hirama T; Mehrabi M; Brode SK; Marras TK
    Respir Med; 2020 Jun; 167():105967. PubMed ID: 32421543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redevelopment after spontaneous sputum conversion in noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kim OH; Chong YP; Shim TS; Jo KW
    J Infect Chemother; 2021 Aug; 27(8):1156-1161. PubMed ID: 33745810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Treatment Outcomes of Pulmonary Diseases Caused by Coinfections With Multiple Nontuberculous Mycobacterial Species.
    Kim S; Woo A; Yong SH; Leem AY; Lee SH; Lee SH; Kim SY; Chung K; Kim EY; Jung JY; Kang YA; Park MS; Kim YS; Park Y
    J Korean Med Sci; 2024 May; 39(20):e167. PubMed ID: 38804011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
    Moon SM; Jhun BW; Baek SY; Kim S; Jeon K; Ko RE; Shin SH; Lee H; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Respir Med; 2019 May; 151():1-7. PubMed ID: 31047103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
    Kim HJ; Lee JS; Kwak N; Cho J; Lee CH; Han SK; Yim JJ
    BMC Pulm Med; 2019 Nov; 19(1):212. PubMed ID: 31711459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use.
    Kim SM; Chong YP; Lee HJ; Shim TS; Jo KW
    Microbiol Spectr; 2023 Jun; 11(3):e0474122. PubMed ID: 37022189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Old age is associated with worse treatment outcome and frequent adverse drug reaction in Mycobacterium avium complex pulmonary disease.
    Kim JY; Kim NY; Jung HW; Yim JJ; Kwak N
    BMC Pulm Med; 2022 Jul; 22(1):269. PubMed ID: 35836160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
    Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H
    Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease by Single Bacterial Isolation Plus Anti-GPL-Core IgA Antibody.
    Kawasaki T; Kitada S; Fukushima K; Akiba E; Haduki K; Saito H; Nitta T; Kawano A; Miyazaki A; Nii T; Kuge T; Koba T; Matsuki T; Tsujino K; Miki K; Maekura R; Kida H
    Microbiol Spectr; 2022 Feb; 10(1):e0140621. PubMed ID: 34985326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
    Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W
    Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bigger problems from smaller colonies: emergence of antibiotic-tolerant small colony variants of Mycobacterium avium complex in MAC-pulmonary disease patients.
    Park HE; Kim KM; Trinh MP; Yoo JW; Shin SJ; Shin MK
    Ann Clin Microbiol Antimicrob; 2024 Mar; 23(1):25. PubMed ID: 38500139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.